Lumida
/CGON
⌘K
CG Oncology Inc

CG Oncology Inc

CGON
$71.85USD+3.38%+2.35 today

MARKET CAP

6.3B

P/E (TTM)

FWD P/E

DAY RANGE

$69 – $73

52W RANGE

$24
$77

AI Summary

Stalk
Buy NowMedium

CGON remains in a Stage 2 advancing corrective reset with persistent higher highs and higher lows intact. Price recently pulled back into and held above rising short-term EMAs and the 50 DMA, providing a favorable pullback entry under a momentum + EPS strategy. Short-term timing conditions are Bullish as price tracks above rising EMAs with no exhaustion visible, supporting a Buy Now execution. The primary risk is a deeper pullback below the EMAs and the 50 DMA, which would invalidate the bullish posture.

  • Analysts set $92.50 target, implying 53% upside.
  • Lead therapy shows 76% complete response durability.
  • Earnings yield is –1.97%, indicating weak profitability.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRIC
TREND